I agree that this site is using cookies. You can find further informations here.
X
Encabo, G.
56  results:
Search for persons X
?
1

682 When to start antiresorptive treatment in prostate canc..:

Lorente, Garcia D. ; Planas, J. ; Celma, A....
European Urology Supplements.  12 (2013)  1 - p. e682 , 2013
Link: https://doi.org/10.1016/..
 
?
2

676 AXIAL VERSUS PERIPHERAL DXA SCAN TO ASSESS OSTEOPOROSIS..:

Morote, J. ; Planas, J. ; Raventos, C.X...
European Urology Supplements.  9 (2010)  2 - p. 222 , 2010
Link: https://doi.org/10.1016/..
 
?
3

PREVALENCE OF OSTEOPOROSIS IN PROSTATE CANCER PATIENTS UNDE..:

Planas, J. ; Abascal, J.M. ; Orsola, A....
European Urology Supplements.  5 (2006)  2 - p. 56 , 2006
Link: https://doi.org/10.1016/..
 
?
4

CHANGES IN BONE MINERAL DENSITY IN PROSTATE CANCER PATIENTS..:

Trilla, E. ; Abascal, J.M. ; Planas, J....
European Urology Supplements.  5 (2006)  2 - p. 56 , 2006
Link: https://doi.org/10.1016/..
 
?
5

Bone Mineral Density in patients with Myelomeningocele:

Pagés, E ; Sánchez, J ; Iborra, J...
Cerebrospinal Fluid Research.  2 (2005)  S1 - p. , 2005
Link: https://doi.org/10.1186/..
 
?
6

216 Evaluation of the osteoporosis risk according to the me..:

Abascal, J.M. ; Esquena, S. ; Trilla, E...
European Urology Supplements.  3 (2004)  2 - p. 56 , 2004
Link: https://doi.org/10.1016/..
 
?
7

Analysis of Bone Alkaline Phosphatase as a Marker for the D..:

Morote, J. ; Trilla, E. ; Esquena, S....
The International Journal of Biological Markers.  18 (2003)  4 - p. 290-294 , 2003
Link: https://doi.org/10.1177/..
 
?
8

Osteoporosis during Continuous Androgen Deprivation: Influe..:

Morote, J ; Martinez, E ; Trilla, E...
European Urology.  44 (2003)  6 - p. 661-665 , 2003
Link: https://doi.org/10.1016/..
 
?
9

Influence of the modality and length of continuous androgen..:

Morote, J. ; Martinez, E. ; Trilla, E....
European Urology Supplements.  2 (2003)  1 - p. 187 , 2003
Link: https://doi.org/10.1016/..
 
?
10

Prediction of Prostate Volume Based on Total and Free Serum..:

Morote, J. ; Encabo, G. ; López, M..
European Urology.  38 (2000)  1 - p. 91-95 , 2000
Link: https://doi.org/10.1159/..
 
?
11

Use of Percent Free Prostate–Specific Antigen as a Predicto..:

Morote, J. ; Encabo, G. ; de Torres, I.M.
European Urology.  38 (2000)  2 - p. 225-229 , 2000
Link: https://doi.org/10.1159/..
 
?
12

Effect of Inflammation and Benign Prostatic Enlargement on ..:

Morote, J. ; Lopez, M. ; Encabo, G..
European Urology.  37 (2000)  5 - p. 537-540 , 2000
Link: https://doi.org/10.1159/..
 
?
13

Value of Routine Transition Zone Biopsies in Patients Under..:

Morote, J. ; López, M. ; Encabo, G..
European Urology.  35 (1999)  4 - p. 294-297 , 1999
Link: https://doi.org/10.1159/..
 
?
14

Analytical and Clinical Evaluation of a Procedure for Measu..:

Ortega, M.D. ; Maestro, M.L. ; Encabo, G....
Tumor Biology.  17 (1996)  2 - p. 110-116 , 1996
Link: https://doi.org/10.1159/..
 
?
15

Clinical Profile of a New Monoclonal Antibody-Based Immunoa..:

Correale, M. ; Arnberg, H. ; Blockx, P....
The International Journal of Biological Markers.  9 (1994)  4 - p. 231-238 , 1994
Link: https://doi.org/10.1177/..
 
1-15